U.S. Compounding Pharmacies Market Key Players : Absolute Pharmacy, B. Braun Medical, Baxter, Cantrell Drug Company, Central Compounding Center, Clinigen Group, Dougherty’s Pharmacy, Fagron, Fresenius Kabi, ICU Medical, Institutional Pharmacy Solutions,

U.S. Compounding Pharmacies Market size was valued over USD 4.5 billion in 2017 and is expected to witness more than 5% CAGR from 2018 to 2025.

Growing demand for compounded medicine will serve to be a key factor that will drive the U.S. compounding pharmacies market growth. Convenience and benefits offered by compounding pharmacies such as ability to compound medications that are not produced commercially or formulate liquid doses for patient with difficulty in swallowing pills will increase the adoption of compounded drugs. Customized medication prepared by compounding pharmacies can thus provide better health outcomes for majority of patients, thereby augmenting the compounding pharmacies industry size.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/2961

Furthermore, drug shortage in North America over past few years has affected the U.S. population. Increasing shortage of drugs for diseases such as cardiac disease, diabetes, cancer and other emergency drugs will surge the demand of compounded drugs. Timely unavailability of standard drugs due to production delay, discontinuation of previously manufactured drugs as well as limited capacity of facilities will further stimulate the compounding pharmacies business growth.

Serious and fatal healthcare associated infections caused due to administration of contaminated compounded medication may render negative impact on the industry growth. Continuously changing regulatory specifications pertaining to compounding medication may further impede the regional business growth.

Non-sterile segment held the highest share of 67.7% in 2017 owing to increasing adoption of oral medication that offers convenience and ease of administration in patients of all age groups. Growing demand for oral liquid preparation and topical medication for pain management and anti-inflammatory therapies will further propel segment growth.

Topical product segment is estimated to witness 5.3% CAGR over the analysis timeframe owing to increasing demand for topically administered drugs such as muscle relaxants, anti-inflammatories and anesthetics prescribed for pain management and inflammation therapy.

Pediatric application segment held 14.5% market share in 2017 and is estimated to grow significantly during the forthcoming years. Ability of compounding pharmacies to transform standard drugs into flavored dosage and colorful forms will increase its acceptance among the children thereby accelerating the segmental growth.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/2961

Pharmaceutical ingredient alteration (PIA) segment accounted for USD 1.7 billion in 2017 owing to rising demand for drugs compounded in accordance with specific patient needs such as hypoallergenic versions of drugs for individuals allergic to certain dyes or preservatives.

U.S. Compounding Pharmacies Market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:

U.S. compounding pharmacies market, by pharmacy type
• 503A compounding pharmacy
• 503B compounding pharmacy

U.S. compounding pharmacies market, by sterility
• Sterile
• Non-sterile

U.S. compounding pharmacies market, by product
• Oral
o Solid preparations
o Tablets
o Capsules
o Granules
o Powder
o Others
o Liquid preparations
o Solutions
o Suspension
o Emulsion
o Syrup
o Others
• Topical
o Ointments
o Creams
o Gels
o Pastes
o Others
• Rectal
o Suppositories
o Enema
o Others
• Parenteral
o Large volume parenteral (LVP)
o Small volume parenteral (SVP)
• Nasal
• Ophthalmic
• Otic

U.S. compounding pharmacies market, by application
• Pediatric
• Adult
• Geriatric
• Veterinary

U.S. compounding pharmacies market, by compounding type
• Pharmaceutical Ingredient Alteration (PIA)
• Currently Unavailable Pharmaceutical Manufacturing (CUPM)
• Pharmaceutical Dosage Alteration (PDA)
• Others

U.S. compounding pharmacies market, by therapeutic area
• Hormone Replacement
• Pain Management
• Dermatology
• Specialty Drugs
• Nutritional Supplements
• Others

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : http://news-researchers.com/

This release was published on openPR.